Prevalence of Depression and Associated Factor Among COVID-19 Patients After Home Isolation
Article Sidebar
Main Article Content
Abstract
Background: Current studies showed that COVID-19 infection was associated with depression. However, the prevalence of depression in Thai patients was still unclear. To study the prevalence and associated factors of depression in COVID-19 patients after home isolation for six months.
Design: Retrospective-prospective cohort study, descriptive analytic study.
Methods: Three hundred and eighteen COVID-19 home-isolated patients from January 2022 through May 2022 were studied. They were 18 years old and above. Depression screening tested positive (using the 9Q questionnaire scores of 7 or more), Patients were interviewed via telephone to re-evaluate their depression status after six months. Data were analyzed using the Chi-Square and multiple linear regression.
Results: The prevalence of depression among COVID-19 patients for six months after home isolation was 5.03%, 14 patients had mild depression (87.50%), and two patients had moderate depression (12.50%). No factors that significantly affected the occurrence of depression were found.
Conclusions: COVID-19 patients who were depressed while in home isolation and still had depression after six months of quarantine were 5.03%, indicating that the depression was temporary and long-term treatment was unnecessary. Because of telephone scammers during the study period, some patients (28.30%) refused to answer their phones. Therefore, the samples were smaller than the samples that had been initially calculated. The results should be interpreted with caution.
Keywords: COVID-19, depression, home isolation
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The content and information in articles published in the PCFM journal are solely the opinions and responsibilities of the authors. The journal's editorial board does not necessarily agree with or share any responsibility for them.
All articles, information, content, images, etc., published in the PCFM journal are the copyright of the PCFM journal. If any individual or organization wishes to reproduce, distribute, or use any part or the entirety of the content, they must obtain written permission from the PCFM journal beforehand.
References
Kowalski E, Schneider A, Zipfel S, Stengel A, Graf J. SARS-CoV-2 positive and isolated at home: stress and coping depending on psychological burden. Front Psychiatry. 2021;12:748244. PubMed PMID: 34880791
Mary KM, Herranz JJ, Heron M, Andersen AJ, El AT, Melchior M. Impact of COVID-19-like symptoms on occurrence of anxiety/depression during lockdown among the French general population. Plos One. 2021;16(7):e0255158. PubMed PMID: 34310661
Deng J, Zhou F, Hou W, Silver Z, Wong CY, Chang O, Huang E, Zuo QK. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Annals of the New York Academy of Sciences. 2021;1486:90-111.
Hosen I, Al-Mamun F, Mamun MA. Prevalence and risk factors of the symptoms of depression, anxiety, and stress during the COVID-19 pandemic in Bangladesh: a systematic review and meta-analysis. Global Mental Health (Camb). 2021;8:e47. PubMed PMID: 35145709
อัมพร เบญจพลพิทักษ์, ธิติ แสวงธรรม, ศรุตพันธ์ จักรพันธ์ ณ อยุธยา, รุจิรา เข็มเพ็ชร, รักษ์พงศ์ เวียงเจริญ, จิรภัทร กัลยาณพจน์พร, และคณะ. ผลกระทบด้านสุขภาพจิตของประชาชนต่อสถานการณ์ การแพร่ระบาดเชื้อโคโรนาไวรัส (โควิด-19) เขตสุขภาพ 5. นนทบุรี: สถาบันวิจัยระบบสาธารณสุข. 2564. หน้า 1-115.
Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench. 2013;6:14-17.
ธรณินทร์ กองสุข, สุวรรณา อรุณพงศ์ไพศาล, ศุภชัย จันทร์ทอง, เบญจมาศ พฤกษ์กานนท์, สุพัตรา สุขาวห, จินตนา ลี้จงเพิ่มพูน. ความเที่ยงตรงตามเกณฑ์การวินิจฉัยโรคซึมเศร้าของแบบประเมินอาการซึมเศร้า 9 คำถามฉบับปรับปรุงภาษากลาง. วารสารสมาคมจิตแพทย์แห่งประเทศไทย. 2561; 63:321-34.
สุวรรณา อรุณพงศ์ไพศาล, ธรณินทร์ กองสุข, ณรงค์ มณีทอน, เบญจลักษณ์ มณีทอน, กมลเนตร วรรณเสวก, จินตนา ลี้จงเพิ่มพูน, และคณะ. การพัฒนาและความเที่ยงตรงของแบบคัดกรองโรคซึมเศร้าชนิด 2 คำถาม ในชุมชนไทยอีสาน. วารสารสมาคมจิตแพทย์แห่งประเทศไทย. 2550;52:138-48.
Huarcaya-Victoria J, Alarcon-Ruiz CA, Barzola-Farfán W, Cruzalegui-Bazán C, Cabrejos-Espinoza M, Aspilcueta-Montoya G, et al. One-year follow-up of depression, anxiety, and quality of life of Peruvian patients who survived COVID-19. Qual Life Res. 2023;32:139-49.
Evidence reviews for signs and symptoms (update): COVID-19 rapid guideline: managing the long-term effects of COVID-19: Evidence review I. London: National Institute for Health and Care Excellence (NICE); 2021 Nov. PMID: 39405397.
Dai LL, Wang X, Jiang TC, Li PF, Wang Y, Wu SJ, et al. Anxiety and depressive symptoms among COVID-19 patients in Jianghan Fangcang Shelter Hospital in Wuhan, China. PLoS One. 2020;15(8):e0238416. PubMed PMID: 32857826
Rahman MH, Banik G, Ahmed A, Arifeen SE, Hossain AT, Hasan MA, et al. Anxiety and depressive symptoms among COVID-19 patients admitted to three isolation facilities in Bangladesh. Health Psycol Open. 2021;8:20551029211046106. PubMed PMID: 34646569
Wang W, Bian Q, Zhao Y, Li X, Wang W, Du J, Zhang G, Zhou Q, Zhao M. Reliability and validity of the Chinese version of the Patient Health Questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry. 2014;36:539-44.
